Stephen J Elledge

Title: The Innovative Contributions of Stephen J Elledge

Introduction

Stephen J Elledge is a prominent inventor based in Brookline, MA (US), known for his significant contributions to the field of immunology. With a total of five patents to his name, Elledge has made remarkable advancements in identifying immune cell-specific antigens, which are crucial for understanding immune responses.

Latest Patents

Elledge's latest patents include innovative methods and compositions for identifying epitopes. One of the key patents describes methods for identifying immune cell-specific antigens and compositions for use in these methods. Another notable patent outlines antigen presenting cells (APCs) that comprise an exogenous nucleic acid encoding one or more candidate antigens. These candidate antigens are expressed and presented with MHC class I or class II molecules. Additionally, the patent includes a molecular reporter of Granzyme B (GzB) activity and an exogenous inhibitor of caspase-activated deoxyribonuclease (CAD)-mediated DNA degradation. Furthermore, a system for detecting recognized antigen presentation by an antigen presenting cell to a cytotoxic lymphocyte or NK cell is also described.

Career Highlights

Throughout his career, Stephen J Elledge has worked with esteemed institutions such as The Brigham and Women's Hospital, Inc. and The General Hospital Corporation. His work has significantly impacted the field of immunology and has paved the way for further research and development in identifying immune responses.

Collaborations

Elledge has collaborated with notable colleagues, including Tomasz Kula and Mohammad Haj Dezfulian, contributing to various research projects and advancements in his field.

Conclusion

Stephen J Elledge's innovative work and patents have greatly enhanced our understanding of immune cell-specific antigens. His contributions continue to influence the field of immunology and inspire future research endeavors.